WORLD HEALTH ORGANIZATION

FDA approves AstraZeneca's FluMist nasal spray flu vaccine for self-administration, available online next fall. Authorized for ages 2-49, it offers convenience and accessibility, potentially boosting vaccination rates.

Artificial sweeteners like Aspartame, Sucralose, Saccharin, Acesulfame Potassium, Neotame, and Advantame are widely used but have mixed health effects. Stevia and Monk fruit sugar are natural alternatives. Moderation is key, and natural sweeteners are preferred.

WHO evaluates India’s top drug regulator, CDSCO and DCGI, assessing vaccine manufacturing practices.

New migraine drugs like rimegepant and ubrogepant are no more effective than traditional painkillers and even less so than triptans, according to a global analysis. Triptans are recommended as the first line of treatment, with traditional painkillers as a second option for those unable to take triptans due to heart problems.

Quad countries launch a cancer initiative in the Indo-Pacific, focusing on cervical cancer prevention, detection, and treatment. The initiative aims to improve health infrastructure, expand research collaborations, and support cancer care through various commitments from governments and non-government organizations.

FDA approves first self-administered nasal spray flu vaccine, FluMist by AstraZeneca, available online for ages 2-49, aiming to boost vaccination rates.

FDA approves AstraZeneca's FluMist nasal spray flu vaccine for self-administration, available online next fall. Approved for ages 2-49, it offers convenience and accessibility, potentially boosting vaccination rates.

VNVC launched mass dengue fever vaccination using Takeda's Qdenga, effective against all four dengue virus types, reducing hospitalization risk by 90%. The vaccine, approved in May 2024, is crucial for Vietnam due to high reinfection rates. VNVC, a strategic partner with Takeda, aims to reduce dengue's disease burden. Dengue, a WHO top 10 global health threat, has increased tenfold since 2000, with Vietnam ranking second globally in 2022 cases.

Niger launches malaria vaccine campaign in Gaya, aiming to reduce child mortality; RTS,S by GSK added to routine vaccination calendar. Expected to be 75% effective against severe malaria, with 5 million cases and over 5,000 deaths annually in Niger. Complemented by free mosquito nets and preventive medication.

DRC, facing a severe mpox outbreak, received 99,100 vaccine doses from the EU, aiming for nearly 200,000 total. Over 19,000 cases and 650 deaths highlight the urgency. Vaccine logistics are challenging due to DRC's size and infrastructure. The WHO declared mpox an international emergency, prompting global health organizations to contribute. The EMA approved Bavarian Nordic's mpox vaccine for adolescents, emphasizing vulnerable populations. Comprehensive public health measures, including education and community engagement, are crucial alongside vaccination efforts.